| A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (NCT06183216) | Sinovac Research and Development Co., Ltd. | 2024-01-04 |
| Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above (NCT05156632) | Sinovac Research and Development Co., Ltd. | 2023-02-20 |
| Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19 (NCT05165732) | Sinovac Research and Development Co., Ltd. | 2022-12-20 |
| Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey (NCT05150496) | Sinovac Research and Development Co., Ltd. | 2022-12-15 |
| Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose (NCT05367895) | Sinovac Research and Development Co., Ltd. | 2022-07-30 |
| Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above (NCT05381350) | Sinovac Research and Development Co., Ltd. | 2022-06-01 |
| Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong (NCT05254236) | Sinovac Research and Development Co., Ltd. | 2022-02-10 |
| Immunogenicity of an Inactivated COVID-19 Vaccine (NCT05198336) | Sinovac Research and Development Co., Ltd. | 2022-01-08 |
| Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) (NCT04993365) | Sinovac Research and Development Co., Ltd. | 2021-11-05 |
| Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents (NCT04992260) | Sinovac Research and Development Co., Ltd. | 2021-09-10 |
| Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic (NCT04974164) | Sinovac Research and Development Co., Ltd. | 2021-08-17 |
| Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years (NCT05112913) | Sinovac Research and Development Co., Ltd. | 2021-07-27 |
| Immunogenicity and Safety of an Inactivated COVID-19 Vaccine (NCT04953325) | Sinovac Research and Development Co., Ltd. | 2021-07-09 |
| Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults (NCT04962308) | Sinovac Research and Development Co., Ltd. | 2021-06-19 |
| Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults (NCT04911790) | Sinovac Research and Development Co., Ltd. | 2021-06-05 |
| Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults (NCT04894227) | Sinovac Research and Development Co., Ltd. | 2021-05-11 |
| Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine (NCT04801888) | Sinovac Research and Development Co., Ltd. | 2021-03-23 |
| Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults (NCT04617483) | Sinovac Research and Development Co., Ltd. | 2020-10-31 |
| Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 (NCT04551547) | Sinovac Research and Development Co., Ltd. | 2020-10-31 |
| Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) (NCT04352608) | Sinovac Research and Development Co., Ltd. | 2020-04-16 |